Enrique M. Ocio

Enrique M. Ocio

Universidad de Cantabria - Santander / Spain
Others
AD Scientific Index ID: 4361357
University of Cantabria
person_outline Enrique M. Ocio's MOST POPULAR ARTICLES
1-) Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a …JF San-Miguel, VTM Hungria, SS Yoon, M Beksac, MA Dimopoulos, ...The lancet oncology 15 (11), 1195-1206, 20148052014
2-) Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a …M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ...The Lancet 394 (10214), 2096-2107, 20194412019
3-) International prognostic scoring system for Waldenström macroglobulinemiaP Morel, A Duhamel, P Gobbi, MA Dimopoulos, MV Dhodapkar, J McCoy, ...Blood, The Journal of the American Society of Hematology 113 (18), 4163-4170, 20094282009
4-) International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairmentMA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ...Journal of Clinical Oncology 34 (13), 1544-1557, 20164652016
5-) International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disordersJ Hillengass, S Usmani, SV Rajkumar, BGM Durie, MV Mateos, S Lonial, ...The lancet oncology 20 (6), e302-e312, 20194422019